DAFNA Capital Management LLC

DAFNA Capital Management LLC reported 87 holdings worth US$468M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

DAFNA Capital Management LLC reported 87 holdings worth US$468M as of Sep 30, 2026. Largest: Revolution Medicines, Inc., AtriCure, Inc. and COMPASS Pathways Plc. Filed Nov 16, 2026 (Form 13F).

Holdings
87
Value as reported
US$468M

The filing in full

CompanySharesValue as reported% of portfolio
Revolution Medicines, Inc.487KUS$100M21.4%
AtriCure, Inc.523KUS$29.4M6.3%
COMPASS Pathways Plc2.14MUS$26.6M5.7%
State Street SPDR S&P Biotech ETF152KUS$23.9M5.1%
Nektar Therapeutics323KUS$19.6M4.2%
IDEAYA Biosciences, Inc.439KUS$16.9M3.6%
Stereotaxis, Inc.13.7MUS$16.8M3.6%
Denali Therapeutics Inc.744KUS$15.4M3.3%
Arcus Biosciences, Inc.440KUS$11.4M2.4%
Cytokinetics, Incorporated172KUS$11.3M2.4%
Edgewise Therapeutics, Inc.222KUS$9.01M1.9%
Neurocrine Biosciences, Inc.62,716US$8.9M1.9%
Insulet Corporation67,870US$8.85M1.9%
Xenon Pharmaceuticals Inc.205KUS$7.62M1.6%
Axogen, Inc.180KUS$7.54M1.6%
DexCom, Inc.86,279US$7.45M1.6%
Syndax Pharmaceuticals, Inc.331KUS$6.23M1.3%
Larimar Therapeutics, Inc.1.89MUS$6.03M1.3%
Tandem Diabetes Care, Inc.355KUS$5.79M1.2%
Bicara Therapeutics Inc.300KUS$5.58M1.2%
Rapport Therapeutics, Inc.142KUS$4.77M1.0%
Immunovant, Inc.136KUS$4.58M0.98%
Inogen, Inc845KUS$4.45M0.95%
Neurogene Inc.151KUS$4.19M0.89%
Century Therapeutics, Inc.2.39MUS$4.08M0.87%
OrthoPediatrics Corp.179KUS$3.99M0.85%
Lakefront Biotherapeutics130KUS$3.86M0.82%
Stoke Therapeutics, Inc.146KUS$3.8M0.81%
Adlai Nortye Group Ltd.233KUS$3.72M0.80%
Eupraxia Pharmaceuticals, Inc.405KUS$3.68M0.79%
Celldex Therapeutics, Inc.108KUS$3.5M0.75%
Allogene Therapeutics, Inc.2MUS$3.2M0.68%
BioCryst Pharmaceuticals, Inc.380KUS$3.17M0.68%
Kymera Therapeutics, Inc.26,912US$3.01M0.64%
Aquestive Therapeutics, Inc.641KUS$2.97M0.63%
Atrium Therapeutics, Inc.300KUS$2.48M0.53%
iShares Biotechnology ETF11,595US$2.44M0.52%
PROCEPT BioRobotics Corporation120KUS$2.19M0.47%
Cybin, Inc.176KUS$2.16M0.46%
Align Technology, Inc.14,000US$2.03M0.43%
Viking Therapeutics, Inc.54,516US$1.78M0.38%
Maze Therapeutics, Inc.65,000US$1.77M0.38%
Alector, Inc.908KUS$1.68M0.36%
TELA Bio, Inc.1.44MUS$1.66M0.35%
MapLight Therapeutics, Inc.156KUS$1.59M0.34%
NervGen Pharma Corp.811KUS$1.55M0.33%
Structure Therapeutics, Inc.46,500US$1.45M0.31%
Profound Medical Corp225KUS$1.31M0.28%
Design Therapeutics, Inc.102KUS$1.28M0.27%
Lexeo Therapeutics, Inc.377KUS$1.27M0.27%
Inspire Medical Systems, Inc.18,200US$1.26M0.27%
CytomX Therapeutics, Inc.438KUS$1.19M0.25%
Fate Therapeutics, Inc.500KUS$1.19M0.25%
Mineralys Therapeutics, Inc.44,490US$1.12M0.24%
BridgeBio Oncology Therapeutics, Inc.266KUS$1.09M0.23%
Annexon, Inc.258KUS$1.09M0.23%
Biohaven Ltd.77,593US$1.04M0.22%
Q32 Bio Inc.98,500US$815K0.17%
Pyxis Oncology, Inc.345KUS$803K0.17%
ARS Pharmaceuticals, Inc.183KUS$788K0.17%
Ultragenyx Pharmaceutical Inc.51,100US$768K0.16%
Kura Oncology, Inc.69,068US$740K0.16%
BioNTech SE7,000US$688K0.15%
Adicet Bio, Inc.93,812US$670K0.14%
Seaport Therapeutics, Inc.32,400US$654K0.14%
Quoin Pharmaceuticals. Ltd132KUS$603K0.13%
Corbus Pharmaceuticals Holdings, Inc.83,248US$568K0.12%
Pliant Therapeutics, Inc.487KUS$526K0.11%
Editas Medicine, Inc.180KUS$464K0.10%
Accuray Incorporated1.68MUS$454K0.10%
Autolus Therapeutics plc179KUS$348K0.07%
Foghorn Therapeutics Inc.89,659US$320K0.07%
iBio, Inc.170KUS$201K0.04%
Tenaya Therapeutics, Inc.300KUS$181K0.04%
Kazia Therapeutics Ltd15,700US$151K0.03%
Verrica Pharmaceuticals Inc.23,750US$114K0.02%
Kardigan, Inc.5,000US$73,7500.02%
Artiva Biotherapeutics, Inc.0US$00.00%
MBX Biosciences, Inc.0US$00.00%
Nuvectis Pharma, Inc.0US$00.00%
Orchestra BioMed Holdings, Inc.0US$00.00%

Source

Download original · View original at SEC

Related